Biosimilar filgrastim (Zarzio®) vs. lenograstim (Myelostim®) for peripheral blood stem cell mobilization in adult patients with lymphoma and myeloma: a single center experience-Reference-Cited by-同舟云学术

Biosimilar filgrastim (Zarzio®) vs. lenograstim (Myelostim®) for peripheral blood stem cell mobilization in adult patients with lymphoma and myeloma: a single center experience

Published:2015-07-18 Issue:2 Volume:57 Page:489-492
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Marchesi Francesco,Vacca Michele,Gumenyuk Svitlana,Pandolfi Annino,Renzi Daniela,Palombi Francesca,Pisani Francesco,Romano Atelda,Spadea Antonio,Ipsevich Francesco,Santinelli Susanna,De Rienzo Mafalda,Papa Elena,Canfora Marco,Laurenzi Lamberto,Foddai Maria Laura,Pierelli Luca,Mengarelli Andrea

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2015.1063147

Reference15 articles.

1. Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation

2. Comparison of Lenograstim vs Filgrastim Administration following Chemotherapy for Peripheral Blood Stem Cell (PBSC) Collection: A Retrospective Study of 126 Patients

3. A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization

4. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: A randomized study in patients undergoing autologous peripheral stem cell transplantation

5. Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Filgrastim biosimilar (EP2006): A review of 15 years’ post-approval evidence;Critical Reviews in Oncology/Hematology;2024-04

2. Comparison of CD34 + cell mobilization, blood graft cellular composition, and post‐transplant outcome in myeloma patients mobilized with filgrastim or pegfilgrastim added to low‐dose cyclophosphamide: A prospective multicenter study;Transfusion;2021-09-09

3. Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma - Single center experience;Transfusion and Apheresis Science;2021-08

4. Extrapolation in Practice: Lessons from 10 Years with Biosimilar Filgrastim;BioDrugs;2019-08-22

5. Mobilization and Collection of Peripheral Blood Stem Cells in Adults: Focus on Timing and Benchmarking;Stem Cell Mobilization;2019